Abstracts Archive - Page 530 of 1683 - ATC Abstracts

2020 American Transplant Congress
The State of Interventional Clinical Trials in Solid Organ Transplant: Insights from a Systematic Analysis of Clinicaltrials.gov
A. C. Swaminathan¹, J. Li¹, K. Chiswell¹, W. McManigle¹, I. O’Doherty², W. Fitzsimmons³, J. L. Todd¹, S. Tibbs⁴, S. M. Palmer¹
¹Duke Clinical Research Institute, Durham, NC, ²Critical Path Institute, Tuscan, AZ, ³Fitzsimmons LLC, Chicago, IL, ⁴Duke University, Durham, NC
*Purpose: The approach to immunosuppression after solid organ transplant has remained relatively unchanged for almost 20 years, despite the high prevalence of immunosuppression-related complications and…
2020 American Transplant Congress
Implications for Facilitated Pancreas Transplant Allocation with the Removal of Donor Service Area
R. Forbes¹, R. Urban², A. Fox², J. Odorico³, S. Niederhaus⁴
¹Vanderbilt University Medical Center, Nashville, TN, ²United Network for Organ Sharing, Richmond, VA, ³University of Wisconsin, Madison, WI, ⁴University of Maryland, Baltimore, MD
*Purpose: Facilitated Pancreas (FP) Allocation, modified in August 2016 to be metric-based rather than opt-in, defines an eligible center as one that has transplanted at…
2020 American Transplant Congress
Survey of Public Attitudes Towards Imminent Death Donation in the United States
L. Washburn¹, T. Galvan¹, P. Moolchandani¹, S. Rath¹, R. Ackah², S. Parsons³, R. P. Brown³, E. Ranova³, M. Goss⁴, A. Rana¹, J. A. Goss¹
¹Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ²Department of Surgery, Ohio State University, Columbus, OH, ³Rice University, Houston, TX, ⁴Department of Bioethics, Columbia University, New York, NY
*Purpose: Imminent Death Donation (IDD) has been proposed as a method to increase the number of high-quality organs available for transplant. Although IDD was ethically…
2020 American Transplant Congress
Challenges in Examining Transplant Outcomes in Patients with Fontan-Associated Liver Disease
R. T. Fischer¹, M. H. Kim², A. Nguyen³, S. R. Kumar³, J. Bucuvalas⁴, E. F. Glynn¹, M. A. Hoffman¹, J. Emamaullee³
¹Children's Mercy Hospital, Kansas City, MO, ²Children's Hospital-Los Angeles, Los Angeles, CA, ³University of Southern California, Los Angeles, CA, ⁴Mount Sinai Kravis Children's Hospital, New York, NY
*Purpose: The Fontan procedure has allowed patients born with single ventricle physiology to survive into adulthood. It is projected that the mean age of Fontan…
2020 American Transplant Congress
The Heart of the Matter: The Impact of the 2018 Heart Allocation Policy at a Single Organ Procurement Organization
A. J. Boyer, J. B. Nave, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: In 2018, allocation policy changed with the goal of lowering waitlist mortality by increasing access to donor hearts. We sought to describe the impact…
2020 American Transplant Congress
Determinants of Kidney Transplant Candidates’ Willingness to Accept Deceased Donor Organ Intervention Research: A Conjoint Analysis
E. Gordon¹, P. Reese², J. Lee¹, L. Krishnamurthi¹, R. Veatch³, R. Knight⁴, P. T. Conway⁴, S. Dunn⁵, P. Abt²
¹Northwestern University, Chicago, IL, ²University of Pennsylvania, Philadelphia, PA, ³Georgetown University, Washington, DC, ⁴American Association of Kidney Diseases, Tampa, FL, ⁵Organ Alliance, Denver, CO
*Purpose: Deceased donor organ intervention research (“intervention research”) aims to increase organ quality and quantity for transplantation by protecting against organ injury and enhancing functionality.…
2020 American Transplant Congress
Impact of County Health Rankings on Nationwide Liver Transplant Outcomes
S. K. Niazi¹, E. Vargas², A. Spaulding³, J. Crook⁴, A. P. Keaveny⁵, T. Schneekloth⁶, T. Rummans⁷, C. Taner⁵
¹Psychiatry & Psychology; Transplantation, Mayo Clinic, Jacksonville, FL, ²Heath Services Research, Mayo Clinic, Jacksonville, FL, ³Health Services Research, Mayo Clinic, Jacksonville, FL, ⁴Health Sciences Research, Mayo Clinic, Jacksonville, FL, ⁵Transplantation, Mayo Clinic, Jacksonville, FL, ⁶Psychiatry & Psychology, Mayo Clinic, Rochester, MN, ⁷Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL
*Purpose: We examined the impact of social determinants of health (SDOH) in LT recipients’ counties of residence and their associations with long-term patient and graft…
2020 American Transplant Congress
Geographic Distribution of End-Stage Renal Disease in the US: The First Description of an “ESRD Belt”
R. D. Reed¹, H. Qu¹, P. A. MacLennan¹, M. N. Mustian¹, D. Anderson¹, A. C. Kale¹, B. J. Orandi¹, B. A. Shelton¹, V. Kumar², M. J. Hanaway¹, J. E. Locke¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Medicine, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Previous research has demonstrated that population health is associated with organ supply and transplantation; this is particularly true in the southeastern United States, which…
2020 American Transplant Congress
Prevalence, Prognosis and Predictors of Neurological Complications after Heart Transplantation
C. Caraviello, D. Harsanyi, L. Trevizan, F. Bacal, S. Mangini
Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil
*Purpose: Heart transplantation (HT) is considered the gold-standard treatment for end-stage heart failure. In spite of its innumerous benefits, this therapy still involves complications. Among…
2020 American Transplant Congress
Taking it to the Max: Extremely Low LDL May Provide Benefit for Prevention of Cardiac Allograft Vasculopathy
R. Lee¹, E. J. Henricksen¹, Y. Moayedi², K. Y. Feng³, J. Han³, W. Yang⁴, R. Imai¹, J. J. Teuteberg⁴, K. K. Khush⁴
¹Pharmacy, Stanford Health Care, Stanford, CA, ²University Health Network, Toronto, ON, Canada, ³Medicine, Stanford University, Stanford, CA, ⁴Cardiac Transplant, Stanford University, Stanford, CA
*Purpose: Routine use of statins is the only Class I ISHLT recommendation in heart transplantation (HT) to reduce cardiac allograft vasculopathy (CAV) and improve survival.…